EUVIMEDEUVIMED entdecken
Crossref

TPW 2.13 Peri-Operative and Oncological Outcomes of Robotic Colorectal Cancer Surgery at a London District General Hospital: A Two-Year Experience

Anita Golash, Vladimir Milovanov, Mohammed Al Ani, Yas Mohsen, Alistair Myers, Alistair Slesser

British Journal of Surgery · 05.08.2026 · 113 (Supplement_8)

DOI: 10.1093/bjs/znag087.311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2026. Verfasst von Anita Golash und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Robotic platforms are increasingly utilised in colorectal cancer surgery to enhance operative precision, facilitate minimally invasive resection in anatomically complex disease, and potentially optimise peri-operative and oncological outcomes. This study evaluates the safety, perioperative morbidity, and oncological adequacy of robotic colorectal cancer resections over a two-year period at a London district general hospital.

Methods

A retrospective review was performed of patients undergoing robotic colorectal resection for suspected or confirmed malignancy between 2023–2025. Demographic characteristics, postoperative outcomes, complications graded according to the Clavien–Dindo classification, conversion rates, and histopathological findings were analysed descriptively.

Results

A total of 111 patients underwent robotic colorectal resection (63 male and 48 female) with a mean age of 65 years (range 32–90). Anterior resection accounted for 51.4% of cases and right hemicolectomy for 34.2%. Mean operative duration was 5.67 hours. Conversion to open surgery occurred in 9 cases (8.1%). Mean length of stay was 8.79 days (median 6.5). Major complications (Clavien–Dindo grade ≥III) were observed in 9 patients (8.1%), including 7 unplanned returns to theatre. Ileus occurred in 20 patients (18.0%) and anastomotic leak in 8 (7.2%). Ninety-day mortality was 1.8% (n=2). R0 resection was achieved in 95 of 101 cancer cases (94.1%).

Conclusions

Robotic colorectal cancer surgery in this series demonstrated acceptable perioperative morbidity, low conversion rates, and high rates of oncological clearance. The high R0 resection rate and low incidence of major complications support the oncological validity and procedural safety of robotic-assisted colorectal surgery when delivered within a structured service.

Zitieren

APA

Golash, A., Milovanov, V., Ani, M. A., Mohsen, Y., Myers, A., & Slesser, A. (2026). TPW 2.13 Peri-Operative and Oncological Outcomes of Robotic Colorectal Cancer Surgery at a London District General Hospital: A Two-Year Experience. British Journal of Surgery, 113(Supplement_8). https://doi.org/10.1093/bjs/znag087.311

Vancouver

Golash A, Milovanov V, Ani MA, Mohsen Y, Myers A, Slesser A. TPW 2.13 Peri-Operative and Oncological Outcomes of Robotic Colorectal Cancer Surgery at a London District General Hospital: A Two-Year Experience. British Journal of Surgery. 2026;113(Supplement_8). doi:10.1093/bjs/znag087.311

BibTeX
@article{Golash2026,
  author = {Golash, Anita and Milovanov, Vladimir and Ani, Mohammed Al and Mohsen, Yas and Myers, Alistair and Slesser, Alistair},
  title = {TPW 2.13 Peri-Operative and Oncological Outcomes of Robotic Colorectal Cancer Surgery at a London District General Hospital: A Two-Year Experience},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_8},
  doi = {10.1093/bjs/znag087.311}
}
Kostenlos starten →